Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Gadsden Properties, Inc.a50792274_ex99-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 28, 2014

PhotoMedex, Inc.
(Exact Name of Registrant Specified in Charter)

Delaware

  0-11635   59-2058100

(State or Other
Jurisdiction of
Incorporation)

(Commission File
Number)

(I.R.S. Employer

Identification No.)

147 Keystone Drive, Montgomeryville, Pennsylvania

18936

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code:   215-619-3600

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


ITEM 5.02.          Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

PhotoMedex  today announced that on January 15, 2014, Nahum Melumad, Ph.D., a member of the Company’s Board of Directors, and Chairman of its Audit Committee, passed away. Dr. Melumad joined the Board of PhotoMedex following its merger with Radiancy, Inc. in December 2011.  

On January 28, 2014, Stephen Connelly was unanimously appointed by the Board of Directors of the Registrant as interim Chairman of the Audit Committee.  

A copy of the Registrant’s Press Release dated January 29, 2014 announcing these changes is attached hereto as Exhibit 99.1

ITEM 9.01.          Financial Statements and Exhibits.

(d) EXHIBITS.

          99.1      Press Release, dated January 29, 2014


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.

PHOTOMEDEX, INC.

 

 
Date: January 29, 2014 By:

/s/ Dolev Rafaeli

Dolev Rafaeli

Chief Executive Officer



EXHIBIT INDEX

Exhibit No.

Description

99.1

Press Release of the Company, dated January 29, 2014.